The role of molecular epidemiology in low-income, high-burden countries

International Journal of Tuberculosis and Lung Disease

Volumn 13, Issue 4, 2009, Pages 419-420

  Van Der Spuy, G D ^a   Warren, R M ^a   Van Helden, P D ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; TUBERCULOSTATIC AGENT;

BACTERIAL TRANSMISSION; BCG VACCINATION; DRUG SURVEILLANCE PROGRAM; EDITORIAL; EPIDEMIC; HUMAN; LOWEST INCOME GROUP; MOLECULAR EPIDEMIOLOGY; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; TUBERCULOSIS;

EPIDEMIOLOGY, MOLECULAR; HUMANS; MYCOBACTERIUM TUBERCULOSIS; POVERTY; TUBERCULOSIS;

EID: 64549087176     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (13)

1. Ross BC, Raios K, Jackson K, Sievers A, Dwyer B. Differentiation of Mycobacterium tuberculosis strains by use of a nonradioactive Southern blot hybridization method. J Infect Dis 1991; 163: 904-907.
2. Warren R, Hauman J, Beyers N, et al. Unexpectedly high strain diversity of Mycobacterium tuberculosis in a high-incidence community. S Afr Med J 1996; 86: 45-49.
3. Gagneux S, DeRiemer K, Van T, et al. Variable host-pathogen compatibility in Mycobacterium tuberculosis. Proc Natl Acad Sci U S A 2006; 103: 2869-2873.
4. Small P M, Hopewell P C, Singh S P, et al. The epidemiology of tuberculosis in San Francisco. A population-based study using conventional and molecular methods. N Engl J Med 1994; 330: 1703-1709.
5. van der Spuy G D, Warren R M, Richardson M, Beyers N, Behr M A, van Helden P D. Use of genetic distance as a measure of ongoing transmission of Mycobacterium tuberculosis. J Clin Microbiol 2003; 41: 5640-5644.
6. Verver S, Warren R M, Munch Z, et al. Proportion of tuberculosis transmission that takes place in households in a highincidence area. Lancet 2004; 363: 212-214.
7. Braden C R, Morlock G P, Woodley C L, et al. Simultaneous infection with multiple strains of Mycobacterium tuberculosis. Clin Infect Dis 2001; 33: e42-e47.
8. van Rie A, Warren R, Richardson M, et al. Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment. N Engl J Med 1999; 341: 1174-1179.
9. Bifani P J, Plikaytis B B, Kapur V, et al. Origin and interstate spread of a New York City multidrug-resistant Mycobacterium tuberculosis clone family. JAMA 1996; 275: 452-457.
10. Gandhi N R, Moll A, Sturm A W, et al. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 2006; 368: 1575-1580.
11. World Health Organization/International Union Against Tuberculosis and Lung Disease Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Anti-tuberculosis drug resistance in the world. Report no. 4. Geneva, Switzerland: WHO, 2008. http://www.who.int/tb/publications/2008/drs-report4- 26feb08.pdf Accessed February 2009.
12. Hanekom M, van der Spuy G D, Gey van Pittius N C, et al. Discordance between mycobacterial interspersed repetitive-unit- variable-number tandem-repeat typing and IS6110 restriction fragment length polymorphism genotyping for analysis of Mycobacterium tuberculosis Beijing strains in a setting of high incidence of tuberculosis. J Clin Microbiol 2008; 46: 3338-3345.
13. Johnson R, Warren R, Strauss O J, et al. An outbreak of drugresistant tuberculosis caused by a Beijing strain in the Western Cape, South Africa. Int J Tuberc Lung Dis 2006; 10: 1412- 1414.